Cellebrite DI Ltd. Form 6-K Summary
Business Context and Reporting Period
Cellebrite DI Ltd., a foreign private issuer, filed this Form 6-K on September 13, 2022. The filing attaches consolidated financial statements for the three- and six-month periods ended June 30, 2022. The primary purpose of this filing is to satisfy technical requirements under Item 512(a)(4) of Regulation S-K to update the company's registration statement on Form F-1 and to facilitate a conversion to Form F-3.
Key Financial Metrics
The provided text contains the cover page and exhibit index of the Form 6-K but does not include the actual financial statements (Exhibit 99.1). Consequently, specific values for revenue, profit, cash flow, margins, debt, and liquidity are not present in the source text.
Material Changes
The filing text does not provide comparative financial data or commentary on material changes versus prior periods. The document serves as a procedural vehicle to attach financial statements rather than a narrative report on performance changes.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. The document focuses solely on the regulatory mechanism of updating the registration statement.
Investor Verification Checklist
- Verify the actual financial figures by reviewing Exhibit 99.1 (Consolidated financial statements), which is referenced but not included in the provided text.
- Confirm the successful conversion of the registration statement from Form F-1 to Form F-3.
- Review the full Form 6-K filing to access the detailed financial data for the periods ended June 30, 2022.